[1] McGrath JA, Schofield OM,Eady RA. Epidermolysis bullosa pruriginosa: dystrophic epidermolysis bullosa with distinctive clinicopathological features. Br J Dermatol, 1994,130:617-25. [2] Lee JY, Pulkkinen L, Liu HS, et al. A glycine-to-arginine substitution in the triple-helical domain of type VII collagen in a family with dominant dystrophic epidermolysis bullosa pruriginosa. J Invest Dermatol, 1997,108:947-9. [3] Ee HL, Liu L, Goh CL, et al. Clinical and molecular dilemmas in the diagnosis of familial epidermolysis bullosa pruriginosa. J Am Acad Dermatol, 2007,56:S77-81. [4] Fan YM, Yang YP,Li SF. Medical genetics: Sporadic dystrophic epidermolysis bullosa with albopapuloid and prurigo- and folliculitis-like lesions. Int J Dermatol, 2009,48:855-7. [5] Mellerio JE, Ashton GH, Mohammedi R, et al. Allelic heterogeneity of dominant and recessive COL7A1 mutations underlying epidermolysis bullosa pruriginosa. J Invest Dermatol, 1999,112:984-7. [6] 常小丽, 袁丞达, 刘琴, 等. 痒疹样营养不良型大疱性表皮松解症一家系的基因突变检测. 安徽医科大学学报, 2007,42:250-252. [7] 姜薇,杨勇,朱学骏,等.痒疹型营养不良型大疱性表皮松解症一家系的基因突变. 中华皮肤科杂志,2002,35 (6) : 442-444. [8] Shimizu H, Hammami-Hauasli N, Hatta N, et al. Compound heterozygosity for silent and dominant glycine substitution mutations in COL7A1 leads to a marked transient intracytoplasmic retention of procollagen VII and a moderately severe dystrophic epidermolysis bullosa phenotype. J Invest Dermatol, 1999,113:419-21. [9] Nakamura H, Sawamura D, Goto M, et al. The G2028R glycine substitution mutation in COL7A1 leads to marked inter-familiar clinical heterogeneity in dominant dystrophic epidermolysis bullosa. J Dermatol Sci, 2004,34:195-200. |